Insulet | PODD

Stock Price
316.67
Daily Change
6.00 1.93%
Monthly
23.96%
Yearly
96.79%
Q2 Forecast
305.02


Peers Price Chg Day Year Date
Abbott 131.93 -1.33 -1.00% 25.83% May/12
Align Technology 188.91 7.07 3.89% -30.55% May/12
AtriCure 31.81 0.82 2.65% 41.57% May/12
Avanos Medical 13.10 0.45 3.56% -34.10% May/12
Baxter International 31.89 1.00 3.22% -10.66% May/12
Becton, Dickinson and Co. 175.23 8.15 4.88% -25.96% May/12
Boston Scientific 102.76 -0.11 -0.11% 39.39% May/12
Cardinal Health 148.60 0.33 0.22% 51.76% May/12
Cooper Companies 84.40 2.21 2.68% -9.09% May/12
Dexcom 84.99 0.30 0.35% -31.98% May/12
Edwards Lifesciences 74.65 0.94 1.28% -11.89% May/12
Globus Medical 59.01 3.19 5.71% -7.44% May/12
Integra LifeSciences 13.68 1.43 11.67% -47.81% May/12
ICU Medical 144.62 6.32 4.57% 33.45% May/12
J&J 153.89 -0.08 -0.05% 1.76% May/12
Eli Lilly 755.36 21.06 2.87% -0.34% May/12
Masimo 163.56 6.99 4.46% 40.81% May/12
Medtronic 85.72 2.35 2.82% 2.60% May/12
Merit Medical Systems 98.77 2.94 3.07% 22.19% May/12
Insulet 316.67 6.00 1.93% 96.79% May/12
Roche Holding 261.90 4.30 1.67% 15.07% May/12
Solventum Corp 74.80 4.57 6.51% 18.47% May/12
Stryker 387.87 7.01 1.84% 19.69% May/12
Teleflex 129.15 4.17 3.33% -36.58% May/12
Tandem Diabetes Care 23.45 0.47 2.05% -46.62% May/12
West Pharmaceutical Services 219.48 6.47 3.04% -39.72% May/12
Zimmer Biomet Holdings 95.21 0.03 0.03% -21.52% May/12

Indexes Price Day Year Date
USND 18708 779.43 4.35% 14.16% May/12
US2000 2094 71.06 3.51% 1.55% May/12
US500 5835 184.27 3.26% 11.21% May/13

Insulet traded at $316.67 this Monday May 12th, increasing $6.00 or 1.93 percent since the previous trading session. Looking back, over the last four weeks, Insulet gained 23.96 percent. Over the last 12 months, its price rose by 96.79 percent. Looking ahead, we forecast Insulet to be priced at 305.02 by the end of this quarter and at 288.66 in one year, according to Trading Economics global macro models projections and analysts expectations.

Insulet Corporation is primarily engaged in the development, manufacture and sale of its proprietary Omnipod System, a continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod Insulin Management System (Omnipod), the Omnipod DASHTM Insulin Management System (Omnipod DASH) and its digital mobile Omnipod platform. The Omnipod System features two devices: a small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod) and a Personal Diabetes Manager (PDM). Users has to fill the Pod with insulin and wear directly on the body. It can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh or lower back. The Pod delivers precise, personalized doses of insulin into the body through a small flexible tube, cannula. PDM is a wireless, handheld device that programs the Pod with the user’s personalized insulin-delivery instructions and wirelessly monitors the Pod’s operation.